ES2180776T3 - Formulaciones translucidas de colageno. - Google Patents

Formulaciones translucidas de colageno.

Info

Publication number
ES2180776T3
ES2180776T3 ES96915471T ES96915471T ES2180776T3 ES 2180776 T3 ES2180776 T3 ES 2180776T3 ES 96915471 T ES96915471 T ES 96915471T ES 96915471 T ES96915471 T ES 96915471T ES 2180776 T3 ES2180776 T3 ES 2180776T3
Authority
ES
Spain
Prior art keywords
collagen
transluced
formulations
compositions
cytotoxic drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96915471T
Other languages
English (en)
Inventor
Richard E Jones
Mike T Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matrix Pharmaceutical Inc
Original Assignee
Matrix Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Pharmaceutical Inc filed Critical Matrix Pharmaceutical Inc
Application granted granted Critical
Publication of ES2180776T3 publication Critical patent/ES2180776T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCUBREN COMPOSICIONES PROTEINACEAS QUE CONTIENEN COLAGENO Y UNA CANTIDAD EFECTIVA DE UN FARMACO COMPATIBLE CITOTOXICO, LAS CUALES COMPOSICIONES SE CARACTERIZAN POR POSEER UNA TEMPERATURA DE TRANSICION DE COLAGENO UNICA DE MENOS DE APROXIMADAMENTE 45 NTADA DEL FARMACO CITOTOXICO EN EL LUGAR DE LA INYECCION Y SON OPTICAMENTE TRANSLUCIDAS.
ES96915471T 1995-04-28 1996-04-26 Formulaciones translucidas de colageno. Expired - Lifetime ES2180776T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/431,084 US5750146A (en) 1995-04-28 1995-04-28 Translucent collagen formulations with a cytotoxic drug

Publications (1)

Publication Number Publication Date
ES2180776T3 true ES2180776T3 (es) 2003-02-16

Family

ID=23710385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96915471T Expired - Lifetime ES2180776T3 (es) 1995-04-28 1996-04-26 Formulaciones translucidas de colageno.

Country Status (14)

Country Link
US (2) US5750146A (es)
EP (1) EP0825848B1 (es)
JP (1) JPH11504904A (es)
KR (1) KR100437507B1 (es)
CN (1) CN1183039A (es)
AT (1) ATE221370T1 (es)
AU (1) AU719675B2 (es)
CA (1) CA2218037A1 (es)
DE (1) DE69622706T2 (es)
DK (1) DK0825848T3 (es)
ES (1) ES2180776T3 (es)
NZ (1) NZ307791A (es)
PT (1) PT825848E (es)
WO (1) WO1996033696A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077545A (en) * 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US6673370B2 (en) * 2001-05-15 2004-01-06 Biomedicines, Inc. Oxidized collagen formulations for use with non-compatible pharmaceutical agents
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
KR101610985B1 (ko) * 2008-11-14 2016-04-08 히스토젠, 인코포레이티드 암 치료를 위한 세포외 기질 조성물
AU2011329054B2 (en) 2010-11-15 2015-05-28 Zimmer Orthobiologics, Inc. Bone void fillers
US9782457B2 (en) * 2011-10-07 2017-10-10 Tissue Repair Company Flowable formulations for tissue repair and regeneration
US9452240B2 (en) 2013-03-15 2016-09-27 Orthovita, Inc. Pepsinized collagen implants and biomedical uses thereof
WO2019073362A1 (en) * 2017-10-12 2019-04-18 Solyplus Berlin Gmbh METHODS OF MANUFACTURING HOMOGENEOUSLY CONCENTRATED AND HOMOGENOUS MASS POLYMERS AND THEIR APPLICATIONS
US12351620B1 (en) 2023-05-03 2025-07-08 Humabiologics, Inc. Process for production of a soluble and insoluble collagen product from mammalian dermis tissue
US12351621B1 (en) 2023-05-03 2025-07-08 Humabiologics, Inc. Composite collagen product and method of making thereof
US12134792B1 (en) 2023-05-03 2024-11-05 Humabiologics, Inc. Process for production of a soluble and insoluble collagen product from mammalian dermis tissue

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33375A (en) * 1861-10-01 Improvement in pumps
US2589210A (en) * 1945-09-24 1952-03-18 Parke Davis & Co Therapeutic compositions
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
US4230687A (en) * 1978-05-30 1980-10-28 Griffith Laboratories U.S.A., Inc. Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
EP0086627B1 (en) * 1982-02-12 1985-08-28 Unitika Ltd. Anti-cancer device
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
GB8708009D0 (en) * 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
US4863732A (en) * 1987-12-16 1989-09-05 Collagen Corporation Injectable composition for inductive bone repair
DE68901931T2 (de) * 1988-02-11 1992-12-10 Matrix Pharma Zusammensetzungen zur behandlung von gehirn-tumoren.
US5480644A (en) * 1992-02-28 1996-01-02 Jsf Consultants Ltd. Use of injectable biomaterials for the repair and augmentation of the anal sphincters

Also Published As

Publication number Publication date
AU719675B2 (en) 2000-05-18
DE69622706T2 (de) 2003-03-13
US5980946A (en) 1999-11-09
PT825848E (pt) 2002-12-31
AU5723796A (en) 1996-11-18
KR19990008143A (ko) 1999-01-25
DK0825848T3 (da) 2002-11-11
NZ307791A (en) 1999-04-29
ATE221370T1 (de) 2002-08-15
EP0825848A1 (en) 1998-03-04
EP0825848B1 (en) 2002-07-31
US5750146A (en) 1998-05-12
CN1183039A (zh) 1998-05-27
KR100437507B1 (ko) 2004-08-16
DE69622706D1 (de) 2002-09-05
WO1996033696A1 (en) 1996-10-31
EP0825848A4 (en) 1998-08-12
CA2218037A1 (en) 1996-10-31
JPH11504904A (ja) 1999-05-11

Similar Documents

Publication Publication Date Title
ES2180776T3 (es) Formulaciones translucidas de colageno.
NO964976D0 (no) Kopolymer-1-forbedringer kopolymerpreparater
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
IT1276723B1 (it) Formulazioni di analoghi dell'insulina
DE69736228D1 (de) Medizinische stents
SE8903042L (sv) Pharmaceutical compositions comprising cyklosporins
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
ATE263621T1 (de) Diol enthaltende zusammensetzungen
FR2705356B1 (fr) Compositions d'adhésif de pression de silicone.
EE9800123A (et) Stabiilsed lüofiliseeritud ravimvormid
MX203891B (es) Compuestos funcionales de 1, 3-dicetoamida etilenicamente insaturados, polimeros de los mismos y formulaciones de latex que contienen los mismos
FR2714594B3 (fr) Structure de diffuseur pour infusion de plantes médicinales.
DE69108607D1 (de) Künstliche Zahnwurzel.
FI946037A0 (fi) Parannettuja maanviljelykoostumuksia
ATE173578T1 (de) Implantierbare formkörper zur verabreichung von wirkstoffen an pflanzen
DE69608875D1 (de) Härtbare Siliconzusammensetzungen
DE69623861D1 (de) Kniegelenkvollprothese
IT1202426B (it) Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono
NO980296D0 (no) Forbedrede terapeutiske midler
NO942023L (no) Stabiliserte polymersammensetninger
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ITMI950507A0 (it) Composizioni polimeriche autoestinguenti
FR2710673B1 (fr) Composition d'enduit de parement.
SE9702793D0 (sv) Novel formulation
DE69612914D1 (de) Polylaktone aromatische Ester, und dieselben enthaltende Kraftstoffzusammensetzungen